use of pioglitazone for more than one year may be associated with an increased risk of bladder cancer
San Diego, CA (PRWEB) January 03, 2013
AttorneyOne.com, a recognized authority on law, updated the website recently and they are now actively providing expert opinion, taking into consideration the recent news on Actos lawsuits and trials: According to court documents, a lawsuit filed in the Superior Court of Los Angeles (case no. No. CGC-12-518535) alleging bladder cancer caused by Actos is set to go on trial on February 19th, 2013. Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance. Plaintiff claims he developed bladder cancer after using Actos to treat his type 2 diabetes. Judge Kenneth R. Freeman is overseeing the Actos litigation.
On June 12th, 2012, a New York woman filed a $10 million lawsuit in New York Eastern District Court (case no. 2:2012cv02945) alleging she suffered bladder cancer after taking Actos for five years. AttorneyOne will provide all latest information on potential Actos Problems lawsuits.
As Bloomberg reported on March 13th, 2012, Takeda may face as many as 10,000 claims that Actos causes bladder cancer.
Findings of the study published on September 4th, 2012, in the Canadian Medical Association Journal, revealed that Actos (pioglitazone) is associated with an increased risk of bladder cancer among adults with type 2 diabetes.
Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Actos severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Actos lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
On August 17th, 2012, the U.S. Food and Drug Administration announced it approved the first generic version of Actos (pioglitazone hydrochloride) tablets. The product label notes that the use of pioglitazone for more than one year may be associated with an increased risk of bladder cancer.
AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/1/prweb10282762.htm.